| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $254.3M | +35.3% |
| Cost of Revenue | $48.6M | +15.8% |
| Gross Profit | $205.8M | +40.9% |
| R&D Expense | $41.2M | +69.4% |
| SG&A Expense | $62.8M | +45.6% |
| Operating Income | -$36.4M | -1359.0% |
| Pre-tax Income | -$32.9M | -991.8% |
| Income Tax | $931K | +244.8% |
| Net Income | -$33.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $79.8M | -70.4% |
| Accounts Receivable | $3.6M | +62.5% |
| Current Assets | $257.4M | -9.2% |
| Total Assets | $298.7M | -0.5% |
| Current Liabilities | $88.7M | +24.0% |
| Total Liabilities | $98.8M | +32.5% |
| Stockholders' Equity | $199.9M | -11.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.6M | -140.5% |
| Capital Expenditures | $4.2M | +77.9% |
| Investing Cash Flow | -$179.8M | -3781.5% |
| Financing Cash Flow | -$345K | -100.2% |
| Free Cash Flow | -$13.9M | -164.8% |
| -930.4% |
| EPS (Basic) | -$0.24 | -700.0% |
| EPS (Diluted) | -$0.24 | -700.0% |